眼科黏合剂和密封剂市场：2026-2032年全球市场预测（按产品类型、配方、给药途径、分销管道、应用和最终用户划分）

预计到 2025 年，眼科黏合剂和密封剂市场价值将达到 3.7429 亿美元，到 2026 年将成长至 4.1627 亿美元，到 2032 年将达到 7.1173 亿美元，年复合成长率为 9.61%。

主要市场统计数据
基准年 2025	3.7429亿美元
预计年份：2026年	4.1627亿美元
预测年份 2032	7.1173亿美元
复合年增长率 (%)	9.61%

临床、技术、监管和商业性趋势策略概述，塑造眼科黏合剂和密封剂的未来

眼科黏合剂和密封剂市场处于外科创新、生物材料科学和不断发展的临床实践的交汇点。近年来，临床医生一直在寻求替代缝合技术的方案，以提高患者舒适度、缩短手术时间并确保稳定的临床疗效。同时，生物材料化学和器械输送技术的进步拓宽了眼科医师和从业人员可选择的治疗方案。因此，这种融合催生了除传统伤口缝合之外的新应用，例如止血以及晶状体固定和组织粘连等特殊手术。

生物材料、微创手术、监管要求和数位技术的进步如何推动眼科黏合剂和密封剂的综合发展。

眼科黏合剂和密封剂领域正在发生多项变革性变化，重塑着研究、临床实践和商业化的优先顺序。首先，材料科学的突破催生了结合合成聚合物和生物活性成分的混合解决方案，拓展了黏合剂的功能范围，使其不再局限于机械性组织介入，而是能够主动止血和促进组织整合。其次，微创手术技术的进步和门诊手术数量的增加，推动了对能够支持快速应用和稳定治疗效果的製剂和给药系统的需求。

本研究评估了近期贸易政策调整和关税趋势对眼科生物材料的筹资策略、製造地和商业计划的影响。

政策环境和国际贸易措施会对眼科黏合剂和密封剂中使用的医疗设备和生物组件的供应链、原料采购和定价策略产生重大影响。近期主要经济体的关税决策和贸易政策变化，要求供应链进一步多元化，迫使製造商重新评估其组件采购、製造地和库存策略。为此，许多企业正在加速关键生产流程的在地化，并选择替代供应商以降低供应中断的风险。

详细的細項分析揭示了产品类型、配方、给药途径、应用、最终用户和分销管道如何全面决定临床引入和商业策略。

了解基于细分市场的趋势，有助于在整个眼科黏合剂和密封剂领域做出更精准的产品和市场准入决策。在考虑产品类型差异时，黏合剂和密封剂在市场上有所区别，它们各自服务于不同的机械和临床应用，并影响应用技术和器械设计。在配方层面，生物製剂和合成製剂之间存在着明确的界线。生物製药通常含有白蛋白或纤维蛋白成分，优先考虑生物相容性和组织整合性；而合成製剂则利用氰基丙烯酸酯、聚乙二醇（PEG）聚合物和聚氨酯等化学物质，以实现可调的机械性能和多样化的降解特性。

从跨区域观点分析美洲、欧洲、中东和非洲以及亚太市场在监管差异、临床引入模式和供应链策略方面的细微差别。

区域趋势影响眼科黏合剂和密封剂的监管路径、临床医生的偏好以及供应链发展。在美洲，先进的外科中心集中分布，且管理体制强调临床证据，这使得创新配方和给药系统能够被有影响力的关键意见领袖（KOL）快速评估和采纳。因此，人们更重视完善的临床通讯协定和上市后资料收集，以支援这些产品在不同医疗机构的应用。

竞争动态、联盟和生命週期管理策略正在决定哪些公司将制定眼科黏合剂和密封剂的临床标准，并影响这些标准的采用。

眼科黏合剂和密封剂产业的竞争与合作动态正在演变，各公司正优先考虑平台差异化、合规性和有针对性的临床伙伴关係。业内公司正投资研发独特的化学和递送技术，以满足尚未满足的临床需求，例如提高黏合强度和减少复杂眼组织中的发炎反应。许多公司也在寻求与临床研究中心建立策略合作伙伴关係，以加速证据产生并建立一个能够检验临床效用的外科医生网络。

为了加快眼科黏合剂和密封剂的采用，需要采取切实可行的优先措施，协调研发、监管合规计画、供应链弹性和商业策略，以指导高层管理。

产业领导者应采取协调一致的策略，使研发重点与监管、临床和商业要求保持一致。他们应投资于兼顾黏附性和生物相容性的製剂科学，并设计能够无缝整合到典型眼科工作流程中的给药系统，以减少临床实践中的阻力。在产品开发的同时，他们还应实施有针对性的临床证据产生计划，将随机临床评估与可操作的真实世界研究相结合，以建立监管文件和实施方案。

为了确保获得可靠且实用的见解，我们采用了严格的混合方法，结合了对临床医生的初步访谈、对二手文献的检验以及专家检验。

本研究整合了第一手和第二手调查方法，以确保分析的严谨性和实际应用价值。第一手资料收集包括对临床外科医师、采购经理和医疗设备研发经理进行结构化访谈，从而深入了解手术流程、临床医师偏好和采购行为。第二手研究则包括对同侪审查期刊、监管指南、医疗设备註册库和公开临床试验註册库进行系统性回顾，以验证临床表现特征与监管先例的检验。

结论分析强调，与临床医生需求相符的创新、实证应用和运作韧性是眼科黏合剂和密封剂成功的关键决定因素。

眼科黏合剂和密封剂正透过材料创新、手术效率和临床需求的融合，重塑眼科手术实践。无论配方或给药方法如何，最成功的干预措施都将展现出明显的临床益处，无缝融入外科医生的工作流程，并满足监管和采购要求。配方选择——无论是生物来源的选项（如白蛋白和纤维蛋白），还是合成化学物质（如氰基丙烯酸酯、聚乙二醇聚合物和聚氨酯）——将继续决定产品的差异化和临床效用。

目录

第一章：序言

第二章：调查方法

• 调查设计
• 研究框架
• 市场规模预测
• 数据三角测量
• 调查结果
• 调查的前提
• 研究限制

第三章执行摘要

• 首席主管观点
• 市场规模和成长趋势
• 2025年市占率分析
• FPNV定位矩阵，2025
• 新的商机
• 下一代经营模式
• 产业蓝图

第四章 市场概览

• 产业生态系与价值链分析
• 波特五力分析
• PESTEL 分析
• 市场展望
• 上市策略

第五章 市场洞察

• 消费者洞察与终端用户观点
• 消费者体验基准
• 机会映射
• 分销通路分析
• 价格趋势分析
• 监理合规和标准框架
• ESG与永续性分析
• 中断和风险情景
• 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：眼科黏合剂和密封剂市场：按产品类型划分

• 黏合剂
• 密封剂

第九章：眼科黏合剂和密封剂市场（按配方分类）

• 生物来源
  • 白蛋白
  • 纤维蛋白
• 合成
  • 氰基丙烯酸酯
  • PEG系统
  • 聚氨酯

第十章：眼科黏合剂和密封剂市场：依给药途径划分

• 注射药物
• 外用

第十一章：眼科黏合剂和密封剂市场：按分销管道划分

• 直销
• 销售代理
• 网路药房

第十二章：眼科黏合剂和密封剂市场：按应用领域划分

• 止血
• 镜头固定
• 组织沾黏
• 伤口缝合

第十三章：眼科黏合剂和密封剂市场：按最终用户划分

• 门诊手术中心
• 医院
• 眼科诊所

第十四章：眼科黏合剂和密封剂市场：按地区划分

• 北美洲和南美洲
  • 北美洲
  • 拉丁美洲
• 欧洲、中东和非洲
  • 欧洲
  • 中东
  • 非洲
• 亚太地区

第十五章：眼科黏合剂和密封剂市场：按类别划分

• ASEAN
• GCC
• EU
• BRICS
• G7
• NATO

第十六章 眼科黏合剂和密封剂市场：按国家/地区划分

• 我们
• 加拿大
• 墨西哥
• 巴西
• 英国
• 德国
• 法国
• 俄罗斯
• 义大利
• 西班牙
• 中国
• 印度
• 日本
• 澳洲
• 韩国

第十七章：美国眼科黏合剂与密封剂市场

第十八章：中国眼科黏合剂与密封剂市场

第十九章 竞争情势

• 市场集中度分析，2025年
  • 浓度比（CR）
  • 赫芬达尔-赫希曼指数 (HHI)
• 近期趋势及影响分析，2025 年
• 2025年产品系列分析
• 基准分析，2025 年
• 3M Company
• B. Braun Melsungen AG
• Baxter International, Inc.
• Becton Dickinson & Company
• Concord Drugs Ltd.
• Connexicon Medical Limited
• Corza Medical
• Cryolife Inc.
• CSL Behring LLC
• Grena Ltd.
• HB Fuller Company
• Johnson & Johnson Services, Inc.
• Ocular Therapeutix, Inc.
• Reliance Life Sciences
• Stryker Corporation
• Surgitech Innovation
• Vivostat A/S

The Ocular Adhesives & Sealants Market was valued at USD 374.29 million in 2025 and is projected to grow to USD 416.27 million in 2026, with a CAGR of 9.61%, reaching USD 711.73 million by 2032.

KEY MARKET STATISTICS
Base Year [2025]	USD 374.29 million
Estimated Year [2026]	USD 416.27 million
Forecast Year [2032]	USD 711.73 million
CAGR (%)	9.61%

A strategic overview of the clinical, technological, regulatory, and commercial dynamics shaping the future of ocular adhesives and sealants

The ocular adhesives and sealants landscape sits at the intersection of surgical innovation, biomaterials science, and evolving clinical practice. In recent years clinicians have sought alternatives to suture-based techniques that offer improved patient comfort, reduced procedure time, and consistent clinical outcomes. At the same time, advances in biomaterial chemistry and device delivery technologies have expanded the palette of therapeutic options available to ophthalmic surgeons and proceduralists. Consequently, this convergence has unlocked new applications beyond traditional wound closure, including hemostasis and specialized tasks like lens fixation and tissue adhesion.

Transitioning from concept to clinical adoption requires synchronized progress across regulatory clarity, clinician training, and supply chain reliability. Developers are increasingly prioritizing formulations that balance adhesive strength with biocompatibility and ease of application. In parallel, the distribution and commercialization models are maturing, with direct sales channels and distributor partnerships playing crucial roles in enabling adoption across ambulatory surgical centers, hospitals, and ophthalmic clinics. These dynamics set the stage for practitioners and industry stakeholders to make informed choices about investment, clinical trials, and post-market surveillance strategies.

How concurrent advances in biomaterials, minimally invasive surgery, regulatory expectations, and digital enablement are driving an integrated evolution in ophthalmic adhesives and sealants

Several transformative shifts are reordering priorities across research, clinical practice, and commercialization in the ocular adhesives and sealants field. First, material science breakthroughs are producing hybrid solutions that combine synthetic polymers with bioactive components, which in turn are expanding the functional scope of adhesives beyond mechanical approximation to include active hemostasis and tissue integration. Second, minimally invasive surgical techniques and growing volumes of ambulatory procedures have increased demand for formulations and delivery systems that support rapid application and consistent outcomes.

Concurrently, regulatory pathways and payer scrutiny are steering developers toward clearer evidence-generation strategies. Manufacturers are responding by designing clinical programs that emphasize real-world performance metrics, patient-reported outcomes, and device-user ergonomics. Digital health enablers, such as procedure documentation and remote training platforms, are accelerating clinician uptake and scaling educational efforts. Taken together, these shifts create a more integrated ecosystem where innovations in chemistry, delivery, clinical validation, and commercialization reinforce one another and accelerate the translation of novel adhesives and sealants into routine ophthalmic practice.

Evaluating how recent trade policy adjustments and tariff developments are reshaping sourcing strategies, manufacturing footprints, and commercial planning for ocular biomaterials

The policy environment and international trade measures can exert material influence on supply chains, ingredient sourcing, and pricing strategies for medical device and biologic components used in ocular adhesives and sealants. Recent tariff decisions and trade policy shifts in major economies have necessitated greater supply chain diversification and have prompted manufacturers to reassess component sourcing, manufacturing footprint, and inventory strategies. In response, many organizations are accelerating localization of critical manufacturing steps and qualifying alternative suppliers to mitigate the risk of supply disruption.

Moreover, procurement teams and commercial leads are increasingly incorporating tariff exposure into contract negotiations and total cost of ownership analyses. This implies more rigorous scenario planning for clinical trials, regulatory submissions, and product launches across different regions. From a strategic perspective, firms that proactively adjust sourcing strategies, enhance supplier redundancy, and optimize logistics will be better positioned to maintain clinical supply continuity and protect margins under fluctuating trade conditions.

Deep segmentation analysis revealing how product types, formulations, routes, applications, end users, and distribution channels collectively determine clinical adoption and commercial strategy

Understanding segmentation-driven dynamics enables sharper product and go-to-market decisions across the ocular adhesives and sealants space. When considering product type differentiation, the market distinguishes between adhesives and sealants, each serving distinct mechanical and clinical purposes with implications for application technique and device design. Formulation-level segmentation draws a clear line between biological and synthetic approaches; biological formulations commonly incorporate albumin or fibrin components and emphasize biocompatibility and tissue integration, whereas synthetic formulations leverage chemistries such as cyanoacrylate, PEG-based polymers, and polyurethane to deliver tunable mechanical properties and variable degradation profiles.

Route of administration matters for both clinical workflow and regulatory classification, as developers target injectable solutions for posterior or intraocular applications and topical formats for anterior procedures and wound access. Application-focused segmentation highlights use cases including hemostasis, lens fixation, tissue adhesion, and wound closure, each of which imposes unique performance and safety requirements. End-user segmentation underscores differing adoption pathways and purchasing behaviors among ambulatory surgical centers, hospitals, and ophthalmic clinics, influencing training, reimbursement interactions, and inventory strategies. Finally, distribution channels-ranging from direct sales to partnerships with distributors and transactions via online pharmacies-shape service models, product support expectations, and post-market surveillance mechanisms. Integrating these segmentation lenses informs product design, clinical evidence generation, and tailored commercial approaches that align with clinician workflows and institutional procurement practices.

Cross-regional perspectives on regulatory nuance, clinical adoption patterns, and supply chain strategies across the Americas, Europe Middle East & Africa, and Asia-Pacific markets

Regional dynamics influence regulatory pathways, clinician preferences, and supply chain architectures for ocular adhesives and sealants. In the Americas, a strong concentration of advanced surgical centers and a regulatory regime that emphasizes clinical evidence create an environment where novel formulations and delivery systems can be rapidly evaluated and adopted by influential key opinion leaders. This drives an emphasis on robust clinical protocols and post-market data capture to support adoption across diverse care settings.

Across Europe, the Middle East & Africa, regulatory harmonization efforts and regional procurement dynamics vary significantly, prompting manufacturers to tailor registration strategies and commercial models to local requirements. In some jurisdictions, cost containment pressures and hospital purchasing group dynamics necessitate a focus on value demonstration and ease of training. The Asia-Pacific region exhibits a mix of rapidly modernizing healthcare infrastructures and high-volume surgical throughput centers, which creates demand for scalable, cost-effective solutions and localized manufacturing partnerships. Collectively, these regional variations require flexible regulatory planning, adaptable training programs, and distribution strategies that respect local clinical practice patterns and procurement processes.

How competitive dynamics, collaborations, and lifecycle management strategies are determining which companies set clinical standards and influence adoption for ocular adhesives and sealants

Competitive and collaborative dynamics among companies active in ocular adhesives and sealants have evolved to prioritize platform differentiation, regulatory navigation, and targeted clinical partnerships. Industry players are investing in proprietary chemistries and delivery technologies to address unmet clinical needs such as improving adhesive strength in challenging ocular tissues and reducing inflammatory responses. Many organizations are also seeking strategic collaborations with clinical research centers to expedite evidence generation and establish surgeon champions who can validate real-world utility.

At the same time, consolidation and licensing arrangements are common as manufacturers balance the capital intensity of late-stage clinical trials with the need to scale commercial operations. Companies that combine deep regulatory expertise with agile development processes and strong clinician engagement models tend to secure favorable adoption trajectories. Furthermore, firms that prioritize lifecycle management-iterative product improvements driven by post-market feedback-can strengthen competitive positioning and create enduring clinical preference.

Practical, prioritized actions for executives to align R&D, regulatory planning, supply chain resilience, and commercial tactics to accelerate adoption of ocular adhesive and sealant technologies

Industry leaders should adopt a coordinated strategy that aligns R&D priorities with regulatory, clinical, and commercial imperatives. Invest in formulation science that balances adhesive performance with biocompatibility, and design delivery systems that integrate effortlessly into common ophthalmic workflows to reduce friction at the point of care. Parallel to product development, implement targeted clinical evidence generation plans that pair randomized clinical evaluation with pragmatic real-world studies to build both regulatory dossiers and adoption narratives.

Operationally, diversify supplier bases and consider regional manufacturing or packaging capabilities to hedge against trade-related disruptions. From a commercialization perspective, tailor engagement strategies to end users: develop focused education and training packages for ambulatory surgical centers, extensive clinical support and service agreements for hospitals, and practical implementation guides for ophthalmic clinics. Finally, pursue partnerships that accelerate access to high-volume procedure centers and leverage digital training tools to scale surgeon familiarity and competency with new adhesive and sealant technologies.

A rigorous mixed-methods approach combining primary clinician interviews, secondary literature triangulation, and expert validation to ensure reliable and actionable insights

This research synthesizes primary and secondary methodologies to ensure analytical rigor and practical relevance. Primary data collection included structured interviews with clinical surgeons, procurement directors, and device development leaders, which provided contextual insights into procedural workflows, clinician preferences, and purchasing behavior. Secondary research incorporated a systematic review of peer-reviewed journals, regulatory guidances, device registries, and publicly available clinical trial registries to triangulate clinical performance attributes and regulatory precedents.

Analytical methods combined qualitative thematic analysis of stakeholder interviews with cross-validation against secondary sources. Validation exercises included expert panel reviews and iterative reconciliations where discrepancies were identified. Limitations of the methodology are acknowledged: while efforts were made to secure diverse perspectives across geographies and care settings, rapidly evolving clinical practices and local reimbursement nuances may produce variability that requires ongoing surveillance. Consequently, the findings should be used as a directional guide to inform strategy, while recognizing the need for continuous market monitoring and targeted primary research for specific product or geographic questions.

Concluding analysis emphasizing clinician-aligned innovation, evidence-led adoption, and operational resilience as the critical determinants of success in ocular adhesives and sealants

Ocular adhesives and sealants represent a convergence of material innovation, procedural efficiency, and clinical need that is reshaping ocular surgery practice. Across formulations and delivery modalities, the most successful interventions will be those that demonstrate clear clinical benefits, integrate with surgeon workflows, and align with regulatory and procurement expectations. The interplay of formulation choices-whether biological options like albumin and fibrin or synthetic chemistries such as cyanoacrylate, PEG-based polymers, and polyurethane-will continue to define product differentiation and clinical utility.

Stakeholders who align development priorities with end-user requirements, pursue robust evidence generation, and build resilient supply chains will be better positioned to translate technological promise into sustained clinical adoption. Ultimately, pragmatic strategies that balance innovation with operational excellence and clinician-centric commercialization will determine which solutions achieve meaningful traction in diverse care settings.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Porter's Five Forces Analysis
• 4.4. PESTLE Analysis
• 4.5. Market Outlook
  • 4.5.1. Near-Term Market Outlook (0-2 Years)
  • 4.5.2. Medium-Term Market Outlook (3-5 Years)
  • 4.5.3. Long-Term Market Outlook (5-10 Years)
• 4.6. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Ocular Adhesives & Sealants Market, by Product Type

• 8.1. Adhesives
• 8.2. Sealants

9. Ocular Adhesives & Sealants Market, by Formulation

• 9.1. Biological
  • 9.1.1. Albumin
  • 9.1.2. Fibrin
• 9.2. Synthetic
  • 9.2.1. Cyanoacrylate
  • 9.2.2. PEG-Based
  • 9.2.3. Polyurethane

10. Ocular Adhesives & Sealants Market, by Route of Administration

• 10.1. Injectable
• 10.2. Topical

11. Ocular Adhesives & Sealants Market, by Distribution Channel

• 11.1. Direct Sales
• 11.2. Distributors
• 11.3. Online Pharmacies

12. Ocular Adhesives & Sealants Market, by Application

• 12.1. Hemostasis
• 12.2. Lens Fixation
• 12.3. Tissue Adhesion
• 12.4. Wound Closure

13. Ocular Adhesives & Sealants Market, by End User

• 13.1. Ambulatory Surgical Centers
• 13.2. Hospitals
• 13.3. Ophthalmic Clinics

14. Ocular Adhesives & Sealants Market, by Region

• 14.1. Americas
  • 14.1.1. North America
  • 14.1.2. Latin America
• 14.2. Europe, Middle East & Africa
  • 14.2.1. Europe
  • 14.2.2. Middle East
  • 14.2.3. Africa
• 14.3. Asia-Pacific

15. Ocular Adhesives & Sealants Market, by Group

• 15.1. ASEAN
• 15.2. GCC
• 15.3. European Union
• 15.4. BRICS
• 15.5. G7
• 15.6. NATO

16. Ocular Adhesives & Sealants Market, by Country

• 16.1. United States
• 16.2. Canada
• 16.3. Mexico
• 16.4. Brazil
• 16.5. United Kingdom
• 16.6. Germany
• 16.7. France
• 16.8. Russia
• 16.9. Italy
• 16.10. Spain
• 16.11. China
• 16.12. India
• 16.13. Japan
• 16.14. Australia
• 16.15. South Korea

17. United States Ocular Adhesives & Sealants Market

18. China Ocular Adhesives & Sealants Market

19. Competitive Landscape

• 19.1. Market Concentration Analysis, 2025
  • 19.1.1. Concentration Ratio (CR)
  • 19.1.2. Herfindahl Hirschman Index (HHI)
• 19.2. Recent Developments & Impact Analysis, 2025
• 19.3. Product Portfolio Analysis, 2025
• 19.4. Benchmarking Analysis, 2025
• 19.5. 3M Company
• 19.6. B. Braun Melsungen AG
• 19.7. Baxter International, Inc.
• 19.8. Becton Dickinson & Company
• 19.9. Concord Drugs Ltd.
• 19.10. Connexicon Medical Limited
• 19.11. Corza Medical
• 19.12. Cryolife Inc.
• 19.13. CSL Behring LLC
• 19.14. Grena Ltd.
• 19.15. H.B. Fuller Company
• 19.16. Johnson & Johnson Services, Inc.
• 19.17. Ocular Therapeutix, Inc.
• 19.18. Reliance Life Sciences
• 19.19. Stryker Corporation
• 19.20. Surgitech Innovation
• 19.21. Vivostat A/S

LIST OF FIGURES

• FIGURE 1. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 2. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SHARE, BY KEY PLAYER, 2025
• FIGURE 3. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET, FPNV POSITIONING MATRIX, 2025
• FIGURE 4. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 5. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY FORMULATION, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 6. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 7. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 8. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 9. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 10. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 11. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 12. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 13. UNITED STATES OCULAR ADHESIVES & SEALANTS MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 14. CHINA OCULAR ADHESIVES & SEALANTS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

• TABLE 1. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 2. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
• TABLE 3. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY ADHESIVES, BY REGION, 2018-2032 (USD MILLION)
• TABLE 4. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY ADHESIVES, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 5. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY ADHESIVES, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 6. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY SEALANTS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 7. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY SEALANTS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 8. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY SEALANTS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 9. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
• TABLE 10. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY BIOLOGICAL, BY REGION, 2018-2032 (USD MILLION)
• TABLE 11. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY BIOLOGICAL, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 12. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY BIOLOGICAL, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 13. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
• TABLE 14. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY ALBUMIN, BY REGION, 2018-2032 (USD MILLION)
• TABLE 15. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY ALBUMIN, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 16. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY ALBUMIN, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 17. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY FIBRIN, BY REGION, 2018-2032 (USD MILLION)
• TABLE 18. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY FIBRIN, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 19. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY FIBRIN, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 20. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2032 (USD MILLION)
• TABLE 21. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY SYNTHETIC, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 22. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY SYNTHETIC, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 23. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
• TABLE 24. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY CYANOACRYLATE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 25. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY CYANOACRYLATE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 26. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY CYANOACRYLATE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 27. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY PEG-BASED, BY REGION, 2018-2032 (USD MILLION)
• TABLE 28. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY PEG-BASED, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 29. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY PEG-BASED, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 30. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY POLYURETHANE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 31. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY POLYURETHANE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 32. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY POLYURETHANE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 33. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
• TABLE 34. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 35. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY INJECTABLE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 36. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 37. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2032 (USD MILLION)
• TABLE 38. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY TOPICAL, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 39. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY TOPICAL, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 40. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
• TABLE 41. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
• TABLE 42. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 43. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 44. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 45. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 46. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 47. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
• TABLE 48. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 49. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 50. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 51. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY HEMOSTASIS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 52. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY HEMOSTASIS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 53. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY HEMOSTASIS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 54. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY LENS FIXATION, BY REGION, 2018-2032 (USD MILLION)
• TABLE 55. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY LENS FIXATION, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 56. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY LENS FIXATION, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 57. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY TISSUE ADHESION, BY REGION, 2018-2032 (USD MILLION)
• TABLE 58. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY TISSUE ADHESION, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 59. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY TISSUE ADHESION, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 60. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY WOUND CLOSURE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 61. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY WOUND CLOSURE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 62. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY WOUND CLOSURE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 63. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 64. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 65. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 66. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 67. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 68. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 69. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 70. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY OPHTHALMIC CLINICS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 71. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY OPHTHALMIC CLINICS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 72. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY OPHTHALMIC CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 73. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 74. AMERICAS OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
• TABLE 75. AMERICAS OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
• TABLE 76. AMERICAS OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
• TABLE 77. AMERICAS OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
• TABLE 78. AMERICAS OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
• TABLE 79. AMERICAS OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
• TABLE 80. AMERICAS OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
• TABLE 81. AMERICAS OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 82. AMERICAS OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 83. NORTH AMERICA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 84. NORTH AMERICA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
• TABLE 85. NORTH AMERICA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
• TABLE 86. NORTH AMERICA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
• TABLE 87. NORTH AMERICA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
• TABLE 88. NORTH AMERICA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
• TABLE 89. NORTH AMERICA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
• TABLE 90. NORTH AMERICA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 91. NORTH AMERICA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 92. LATIN AMERICA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 93. LATIN AMERICA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
• TABLE 94. LATIN AMERICA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
• TABLE 95. LATIN AMERICA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
• TABLE 96. LATIN AMERICA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
• TABLE 97. LATIN AMERICA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
• TABLE 98. LATIN AMERICA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
• TABLE 99. LATIN AMERICA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 100. LATIN AMERICA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 101. EUROPE, MIDDLE EAST & AFRICA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
• TABLE 102. EUROPE, MIDDLE EAST & AFRICA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
• TABLE 103. EUROPE, MIDDLE EAST & AFRICA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
• TABLE 104. EUROPE, MIDDLE EAST & AFRICA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
• TABLE 105. EUROPE, MIDDLE EAST & AFRICA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
• TABLE 106. EUROPE, MIDDLE EAST & AFRICA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
• TABLE 107. EUROPE, MIDDLE EAST & AFRICA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
• TABLE 108. EUROPE, MIDDLE EAST & AFRICA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 109. EUROPE, MIDDLE EAST & AFRICA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 110. EUROPE OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 111. EUROPE OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
• TABLE 112. EUROPE OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
• TABLE 113. EUROPE OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
• TABLE 114. EUROPE OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
• TABLE 115. EUROPE OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
• TABLE 116. EUROPE OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
• TABLE 117. EUROPE OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 118. EUROPE OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 119. MIDDLE EAST OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 120. MIDDLE EAST OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
• TABLE 121. MIDDLE EAST OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
• TABLE 122. MIDDLE EAST OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
• TABLE 123. MIDDLE EAST OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
• TABLE 124. MIDDLE EAST OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
• TABLE 125. MIDDLE EAST OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
• TABLE 126. MIDDLE EAST OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 127. MIDDLE EAST OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 128. AFRICA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 129. AFRICA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
• TABLE 130. AFRICA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
• TABLE 131. AFRICA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
• TABLE 132. AFRICA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
• TABLE 133. AFRICA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
• TABLE 134. AFRICA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
• TABLE 135. AFRICA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 136. AFRICA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 137. ASIA-PACIFIC OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 138. ASIA-PACIFIC OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
• TABLE 139. ASIA-PACIFIC OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
• TABLE 140. ASIA-PACIFIC OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
• TABLE 141. ASIA-PACIFIC OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
• TABLE 142. ASIA-PACIFIC OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
• TABLE 143. ASIA-PACIFIC OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
• TABLE 144. ASIA-PACIFIC OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 145. ASIA-PACIFIC OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 146. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 147. ASEAN OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 148. ASEAN OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
• TABLE 149. ASEAN OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
• TABLE 150. ASEAN OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
• TABLE 151. ASEAN OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
• TABLE 152. ASEAN OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
• TABLE 153. ASEAN OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
• TABLE 154. ASEAN OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 155. ASEAN OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 156. GCC OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 157. GCC OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
• TABLE 158. GCC OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
• TABLE 159. GCC OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
• TABLE 160. GCC OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
• TABLE 161. GCC OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
• TABLE 162. GCC OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
• TABLE 163. GCC OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 164. GCC OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 165. EUROPEAN UNION OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 166. EUROPEAN UNION OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
• TABLE 167. EUROPEAN UNION OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
• TABLE 168. EUROPEAN UNION OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
• TABLE 169. EUROPEAN UNION OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
• TABLE 170. EUROPEAN UNION OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
• TABLE 171. EUROPEAN UNION OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
• TABLE 172. EUROPEAN UNION OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 173. EUROPEAN UNION OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 174. BRICS OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 175. BRICS OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
• TABLE 176. BRICS OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
• TABLE 177. BRICS OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
• TABLE 178. BRICS OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
• TABLE 179. BRICS OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
• TABLE 180. BRICS OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
• TABLE 181. BRICS OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 182. BRICS OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 183. G7 OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 184. G7 OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
• TABLE 185. G7 OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
• TABLE 186. G7 OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
• TABLE 187. G7 OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
• TABLE 188. G7 OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
• TABLE 189. G7 OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
• TABLE 190. G7 OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 191. G7 OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 192. NATO OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 193. NATO OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
• TABLE 194. NATO OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
• TABLE 195. NATO OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
• TABLE 196. NATO OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
• TABLE 197. NATO OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
• TABLE 198. NATO OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
• TABLE 199. NATO OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 200. NATO OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 201. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 202. UNITED STATES OCULAR ADHESIVES & SEALANTS MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 203. UNITED STATES OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
• TABLE 204. UNITED STATES OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
• TABLE 205. UNITED STATES OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
• TABLE 206. UNITED STATES OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
• TABLE 207. UNITED STATES OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
• TABLE 208. UNITED STATES OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
• TABLE 209. UNITED STATES OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 210. UNITED STATES OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 211. CHINA OCULAR ADHESIVES & SEALANTS MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 212. CHINA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
• TABLE 213. CHINA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
• TABLE 214. CHINA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
• TABLE 215. CHINA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
• TABLE 216. CHINA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
• TABLE 217. CHINA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
• TABLE 218. CHINA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 219. CHINA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)